KirstenHEdmistonMD

General Surgery • Fairfax, VA

Breast, Surgical Oncology (Other than Breast)

System, Chief Surgical Quality Officer

Join to view full profile

Dr. Edmiston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Edmiston's full profile

Already have an account?

Office
8081 Innovation Park Dr
Fairfax, VA 22031
Phone+1 571-472-4724

Fax+1 571-472-0241

Education & Training

University of MarylandResidency, Surgery, 1988 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1988

Certifications & Licensure

CA State Medical License 1993 - Present
VA State Medical License 1997 - 2026
American Board of Surgery Surgery

Awards, Honors, & Recognition

Fellow American College of Surgeons

Clinical Trials

New Individualized Therapy Trial for Metastatic Colorectal Cancer Start of enrollment: 2009 Jun 01
Completed
Phase 1, Phase 2
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01
Completed
Phase 1, Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2

Publications & Presentations

PubMed

ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the...
Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait
Annals of Surgical Oncology. 2023-10-01
17 citations
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I...
Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait
Annals of Surgical Oncology. 2023-10-01
52 citations
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein
JAMA Oncology. 2021-09-16

Press Mentions

New Quality Verification Program for Hospitals Will Benefit Participants in ACS NSQIPOctober 27th, 2021
George Mason University Breast Cancer Treatment Patent Licensed by Targeted PharmaceuticalsJuly 23rd, 2019
Virginia Hospital Uses Patients’ DNA to Customize TreatmentNovember 13th, 2018